Hedge Fund - Biotechnology Value Fund / BVF Inc
Axsome Therapeutics Inc. (AXSM)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $8,357,058 | 0.28% | 45,757 | $139.61 |
| 2 | 2025 - Q3 (2025-09-30) | $59,116,638 | 2.4% | 486,757 | $112.64 |
| 3 | 2025 - Q2 (2025-06-30) | $176,442,170 | 6.3% | 1,690,221 | $105.89 |
| 4 | 2025 - Q1 (2025-03-31) | $197,130,475 | 8.03% | 1,690,221 | $113.93 |
| 5 | 2024 - Q4 (2024-12-31) | $117,444,095 | 3.98% | 1,388,064 | $91.96 |
| 6 | 2024 - Q3 (2024-09-30) | $94,004,020 | 2.74% | 1,046,000 | $87.29 |
| 7 | 2024 - Q2 (2024-06-30) | $76,877,500 | 2.15% | 955,000 | $74.04 |
| 8 | 2024 - Q1 (2024-03-31) | $0 | 0% | 0 | $83.94 |
| 9 | 2023 - Q4 (2023-12-31) | $157,675,749 | 3.94% | 1,981,100 | $66.86 |
| 10 | 2023 - Q3 (2023-09-30) | $148,942,579 | 4.01% | 2,131,100 | $74.75 |
| 11 | 2023 - Q2 (2023-06-30) | $153,140,846 | 4.26% | 2,131,100 | $73.77 |
| 12 | 2023 - Q1 (2023-03-31) | $131,446,248 | 4.8% | 2,131,100 | $65.70 |
| 13 | 2022 - Q4 (2022-12-31) | $135,363,150 | 5.71% | 1,755,000 | $59.77 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center